Literature DB >> 8505749

British gastroenterologists' care profile for patients with inflammatory bowel disease: the need for a patients' charter.

C S Probert1, V Jayanthi, J F Mayberry.   

Abstract

The follow-up of patients with inflammatory bowel disease (IBD) was investigated using a postal questionnaire sent to 359 members of the British Society of Gastroenterology (BSG), of whom 235 replied. Of patients with IBD, 96% were weighed on each out-patient clinic review and over 60% had their full blood count checked. Although few centres (20%) have computerized recall of their patients for cancer surveillance, 96% did perform such surveillance on patients with ulcerative colitis. The mean duration of disease before surveillance was initiated was 9.6 years. Most clinicians (80%) only surveyed patients with disease extending beyond the transverse colon. Despite recent work on cancer risk age is relatively unimportant to 76% of clinicians in their decision to screen or not. Only 24% of clinicians undertake cancer surveillance in patients with Crohn's disease but these use similar criteria in their selection of patients. Few other tests were performed regularly. Clinic services vary considerably from centre to centre, 62% offer open access to patients with IBD, 8% have a stoma nurse in clinic and 17% a dietitian. Eighty-four per cent of respondents provide educational books and 22% videos. Forty-four per cent of clinicians refer patients for advice to fellow sufferers. We believe there should be a uniform minimum standard of care and services available in clinics throughout the United Kingdom and propose a patients' charter to ensure that this occurs. Such care profiles provide guidelines to those who need to develop standards for resource management.

Entities:  

Mesh:

Year:  1993        PMID: 8505749      PMCID: PMC1294003          DOI: 10.1177/014107689308600510

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  6 in total

1.  Epidemiology of inflammatory bowel disease.

Authors:  V Jayanthi; C S Probert; J F Mayberry
Journal:  Q J Med       Date:  1991-01

2.  Malignancy in ulcerative colitis.

Authors:  N Kvist; O Jacobsen; H K Kvist; P Nørgaard; H H Ockelmann; G Schou; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

3.  Effect of information booklet on patients' anxiety levels and consultation rates in Crohn's disease.

Authors:  H Smart; J Mayberry; B Calcraft; J S Morris; J Rhodes
Journal:  Public Health       Date:  1986-05       Impact factor: 2.427

4.  The information needs and fears of patients with inflammatory bowel disease.

Authors:  J Schölmerich; P Sedlak; P Hoppe-Seyler; W Gerok
Journal:  Hepatogastroenterology       Date:  1987-08

5.  Inflammatory bowel disease: patients' expectations in the 1990s.

Authors:  C S Probert; J F Mayberry
Journal:  J R Soc Med       Date:  1991-03       Impact factor: 18.000

6.  A preliminary report on the role of lay counselling amongst patients with inflammatory bowel disease.

Authors:  D Godber; J F Mayberry
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000

  6 in total
  3 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study.

Authors:  J G Williams; W Y Cheung; I T Russell; D R Cohen; M Longo; B Lervy
Journal:  BMJ       Date:  2000-02-26

3.  Patient-initiated appointment systems for adults with chronic conditions in secondary care.

Authors:  Rebecca Whear; Joanna Thompson-Coon; Morwenna Rogers; Rebecca A Abbott; Lindsey Anderson; Obioha Ukoumunne; Justin Matthews; Victoria A Goodwin; Simon Briscoe; Mark Perry; Ken Stein
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.